1. Home
  2. NVCR vs VC Comparison

NVCR vs VC Comparison

Compare NVCR & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • VC
  • Stock Information
  • Founded
  • NVCR 2000
  • VC 2000
  • Country
  • NVCR Switzerland
  • VC United States
  • Employees
  • NVCR N/A
  • VC N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • VC Auto Parts:O.E.M.
  • Sector
  • NVCR Health Care
  • VC Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • VC Nasdaq
  • Market Cap
  • NVCR 2.3B
  • VC 2.4B
  • IPO Year
  • NVCR 2015
  • VC 2000
  • Fundamental
  • Price
  • NVCR $22.09
  • VC $88.61
  • Analyst Decision
  • NVCR Buy
  • VC Strong Buy
  • Analyst Count
  • NVCR 5
  • VC 14
  • Target Price
  • NVCR $33.40
  • VC $125.62
  • AVG Volume (30 Days)
  • NVCR 741.8K
  • VC 378.6K
  • Earning Date
  • NVCR 02-27-2025
  • VC 02-18-2025
  • Dividend Yield
  • NVCR N/A
  • VC N/A
  • EPS Growth
  • NVCR N/A
  • VC N/A
  • EPS
  • NVCR N/A
  • VC 9.82
  • Revenue
  • NVCR $577,738,000.00
  • VC $3,866,000,000.00
  • Revenue This Year
  • NVCR $19.97
  • VC $1.16
  • Revenue Next Year
  • NVCR $2.83
  • VC $1.70
  • P/E Ratio
  • NVCR N/A
  • VC $9.02
  • Revenue Growth
  • NVCR 14.63
  • VC N/A
  • 52 Week Low
  • NVCR $11.70
  • VC $75.75
  • 52 Week High
  • NVCR $34.13
  • VC $121.45
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 36.77
  • VC 59.13
  • Support Level
  • NVCR $21.38
  • VC $79.55
  • Resistance Level
  • NVCR $22.95
  • VC $90.57
  • Average True Range (ATR)
  • NVCR 0.86
  • VC 2.77
  • MACD
  • NVCR 0.01
  • VC 1.09
  • Stochastic Oscillator
  • NVCR 34.25
  • VC 81.14

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated advanced driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America.

Share on Social Networks: